ONCORMED INC has a total of 26 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are BIOO SCIENT CORP, CELERA CORP and GENEOHM SCIENCES CANADA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Israel | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Murphy Patricia D | 16 |
#2 | Olson Sheri J | 12 |
#3 | Zeng Bin | 10 |
#4 | White Marga B | 8 |
#5 | Allen Antonette C | 8 |
#6 | Critz Brenda S | 7 |
#7 | Alvares Christopher P | 7 |
#8 | Rabin Mark B | 6 |
#9 | Schelter Denise B | 6 |
#10 | Eskandari Tara | 3 |
Publication | Filing date | Title |
---|---|---|
US2003235819A1 | Mutations in the BRCA1 gene | |
US2003022184A1 | Coding sequences of the human BRCA1 gene | |
WO9915704A1 | Genetic panel assay for susceptibility mutations in breast and ovarian cancer | |
WO9909164A1 | Coding sequence haplotypes of the human brca2 gene | |
WO9906598A2 | Determining common functional alleles in a population and uses therefor | |
US6083698A | Cancer susceptibility mutations of BRCA1 | |
US6051379A | Cancer susceptibility mutations of BRCA2 | |
WO9805677A1 | Susceptibility mutations for breast and ovarian cancer | |
US5654155A | Consensus sequence of the human BRCA1 gene | |
US5756294A | Susceptibility mutation for breast and ovarian cancer |